In a reverse experiment, depletion of Uev1 in two breast cancer cell lines significantly inhibits AKT pathway activation, indicating that the cellular Uev1 (presumbly Uev1A) level plays a critical role in oncogenic AKT activation. The gene discussed is AKT1; the disease is breast carcinoma.